Contact Information

Division of
Medical Oncology
The Ottawa Hospital Cancer Centre, General Campus

Room: C2321
501 Smyth Road
Ottawa, ON
Canada K1H 8L6

Tel: 613-737-7700 ext. 70166
Fax: 613-247-3511

Email us

Eastern Canada Colorectal Cancer Consensus Conference 2016 (EC5)


Registration

Registration now open!

EC5 - Eastern Canada Colorectal Cancer Consensus Conference
February 4-6, 2016
Hôtel Nelligan
106 Saint-Paul Street West
Montreal, QC
H2Y 1Z3

Pricing
Category Earlybird Fee
on or before Jan 9, 2016
Regular Fee
after Jan 10, 2016
Physician $125.00 $150.00
Resident/Fellow $50.00 $50.00
Save by registering online! If you are registering by mail or fax add: $5.00 (Manual Registration Fee)
  • Fee includes reception February 4, breakfast, lunch and dinner February 5, breakfast February 6 and refreshment breaks
  • Register online and save on your total registration
  • Registrations will not be processed without full payment
  • Refunds less $75.00 administrative charge will be issued for cancellations received on or before Sunday January 24, 2016. Refunds will not be issued for cancellations received after this date
  • Post-dated cheques are not accepted
  • The University of Ottawa (U of O) reserves the right to cancel courses. Registrants will be notified at the earliest possible date

Hotel Nelligan

106 Saint-Paul Street West
Montreal, QC
H2Y 1Z3

Property Location

With a stay at Hotel Nelligan in Montreal (Old Montreal), you'll be minutes from Montreal Museum of Archaeology and History and Notre Dame Basilica. This 4-star hotel is within close proximity of Place Royale and Old Port.

Rooms

Make yourself at home in one of the 105 rooms featuring iPod docking stations and minibars plus complimentary wireless In-ternet access. Bathrooms have designer toiletries and hair dryers.

Run of House rate

The group rate of $169.00 + taxes
Reservations must be made before January 14th at 5pm
Reservation requests received after the cut-off date will be based on availability at the hotel’s prevailing rates.
Call: 514.788.2040 or 1.877.788.2040 (Quote: OTT0204_001 or Ottawa Hospital Cancer Centre

Online: Go to: www.hotelnelligan.com
Click on "Book Now"
Enter the access code: OTT0204_001

Parking

Overnight Valet: $28 CAD (plus HST). Includes in/out privileges.
Daily parking: $19 (plus HST) per day. Does not include in/out privileges.


Goal

The goal of this conference is to produce a consensus opinion produced by oncologists and allied health profes-sionals from across Eastern Canada for the purpose of recommending management strategies for patients with colorectal cancer (CRC) and selected gastrointestinal cancers. The final report will be submitted for publication to "Current Oncology"; a peer reviewed, Canadian based and internationally distributed journal, representing a multi-disciplinary medium, encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease.


Overall learning objectives of this program

At the end of this program learner will be able to:

  • Describe the optimal treatment of medical, radiation and surgical treatment of Gastrointestinal Cancers
  • Summarize the 2014 GI Consensus and WC5
  • Explain what happens to the colorectal cancer survivor after treatment
  • Interpret optimal management of malignancy in the liver; metastatic and primary and SBRT for oligometastatic disease

Outcome

  • Obtain consensus on new or emerging therapies
  • Publication in "Current Oncology"
  • Discuss standards of care in rectal and Gastro-intestinal cancer

Target Audience From ON, PQ, NB, NS, PEI, NF:

  • Medical and Radiation Oncologists
  • Oncology Surgeons

Program

Thursday, February 4, 2016
Time Event
19:00-21:00 Registration and Welcome Reception

Breast Cancer Survivorship
Time Event Speaker
07:30-07:50

Continental Breakfast & Networking

07:50-08:00

Welcome

Dr. Tim Asmis
08:00-08:30

Review of GI Consensus from 2014

  • Identify variables in NET pathology report influencing decision making and discuss GEP NET treatment options;
  • Develop a competitive plan for advanced/metastatic pancreatic cancer management;
  • Describe the role of EGFR inhibitors in the 1st line treatment of metastatic CRC;
  • Apply CRC screening approaches in practice.
Dr. Elena Tsvetkova
08:30-09:15

An update on the 2015 WC5

  • Identify the goals and framework of the 2015 Western Canadian GI Consensus Meeting
  • Summarize the conclusions of the 2015 Western Canadian GI Consensus Meeting
Dr. Sharlene Gill
09:15-10:00

The Trials and Tribulations of Immunotherapy as a Cancer Treatment

Dr. Xinni Song
10:00-10:15

Break

10:15-11:00

Survivorship and Follow-up of Patient After Treatment of CRC

  • Review follow up guidelines for survivors of resected colorectal cancer
  • Describe the wellness beyond cancer program
Dr. Tim Asmis
11:00-11:45

Prevention of Hepatitis B, HIV, Aids, Hep C and TB

TBD
11:45-13:00

Lunch and Networking

13:00-13:45

Neoadjuvant Therapy in Pancreas - Levels of Evidence

  • Describe the challenges in treating locally advanced pancreatic cancer (LAPC) in thecurative and non-curative settings
  • Explain current and future treatment algorithms for LAPC
  • Identify the mechanisms and associated challenges of drug funding for LAPC inCanada
Dr. Jim Biagi
13:45-14:30

Surgical Options in Pancreatic Cancer

  • Describe the current evidence supporting surgical resection in pancreatic cancer
  • Explain the evolving criteria of resectable pancreatic cancer
  • Describe the options for vascular resection in pancreatic cancer
  • Analyze the current evidence and future directions of pre-operative chemotherapy andradiation in advanced disease.
Dr. Sean Cleary
14:30-14:45

PM break and Networking

14:45-15:30

Role of Radiation in Localized Pancreatic Cancer

  • Explain the indications and types of transarterial therapies for HCC
  • Describe the evidence base for transarterial therapies for HCC
  • Summarize the indications and technical considerations for RFA in the context of HCC
  • Describe the evidence base for RFA for HCC
Dr. James Brierley
18:30-21:00

Dinner


Thursday, February 4, 2016
Time Event Speaker

Adjournment

08:00-08:30

Continental Breakfast & Networking

08:30-09:15

Radiation Treatment for HCC and Bile Duct Cancer

  • Identify the most suitable patients for treatment with stereotactic body radiation therapy (SBRT) or radical radiation therapy (RT)
  • Demonstrate the potential risks of RT in the treatment of hepatobiliary cancers
  • Describe active clinical trials of SBRT and palliative RT for patients with hepatobili-ary cancers
Dr. Laura Dawson
09:15-10:00

Surgical option of Liver Metastic

  • Identify repectability criteria
  • Update current status of adjuvant/neoadjuvant therapy in resectable colorectal livermetastases
  • Review management of synchronous presentation of resectable liver metastasesand colorectal primary
  • Review emerging new issue related to resectable liver metastases
Dr. Prosanto Chaudhury
10:00-10:15

Break

10:15-11:00

Radiation Treatment of Oligometastases

  • Describe stereotactic body radiotherapy (SBRT)
  • Define the role of SBRT in the treatment of metastatic patients
Dr. Neil Kopek
11:00-11:45

Focal tumour ablation options for hepatocellular carcinoma

  • Explain the indications and types of transarterial therapies for HCC
  • Describe the evidence base for transarterial therapies for HCC
  • Summarize the indications and technical considerations for RFA in the context of HCC
  • Describe the evidence base for RFA for HCC
Dr. Guillaume Martel

Planning Committee

Thank you to our planning committee for your participation in planning this event.

Dr. Christine Cripps, Chair
Medical Oncologist
Ottawa Hospital Cancer Centre

Dr. Tim Asmis
Medical Oncologist
Ottawa Hospital Cancer Centre

Dr. James Biagi
Medical Oncologist
Cancer Centre of South Eastern Ontario, Kingston

Dr. Bruce Colwell
Medical Oncologist
QEII Health Sciences Centre

Dr. Conrad Falkson
Radiation Oncologist
Cancer Centre of South Eastern Ontario, Kingston

Dr. Geoff Porter
Surgeon Oncology
Dalhousie University and QEII Health Sciences Centre

Dr. Benoit Samson
Medical Oncologist
Hôpital Charles LeMoyne

Dr. Michael Thirlwell
Medical Oncologist
Montreal General Hospital

Dr. Michael Vickers
Medical Oncologist
Ottawa Hospital Cancer Centre


Sponsors

Thank you to our sponsors for your participation in planning this event.

Amgen Roche Celgene Canada

Additional Information

For further information, please contact:

Jody Chaters
Continuing Professional Development Coordinator
Division of Medical Oncology
The Ottawa Hospital Cancer Centre

Tel: 613-798-5555 ext. 73602
Fax: 613-247-3511
Email: jchaters@toh.on.ca

© University of Ottawa
For additional information, consult our list of contacts
Technical questions? webmaster@uottawa.ca
Last updated: 2016.01.08